United Therapeutics (UTHR) Preferred Stock Liabilities (2012 - 2019)

United Therapeutics (UTHR) has 8 years of Preferred Stock Liabilities data on file, last reported at $8.4 million in Q2 2019.

• For the quarter ending Q2 2019, Preferred Stock Liabilities fell 56.25% year-over-year to $8.4 million; the trailing twelve-month figure through Jun 2019 stood at $8.4 million (down 56.25% YoY), and the FY2018 full-year result was $19.2 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities fell to $8.4 million in Q2 2019, from $19.2 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $20.4 million in Q1 2015 to a low of $8.4 million in Q2 2019.
• A 5-year average of $15.2 million and a median of $16.1 million in 2015 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities plunged 66.6% in 2015 and surged 76.15% in 2017, its largest moves.
• Tracing UTHR's Preferred Stock Liabilities over 5 years: stood at $11.1 million in 2015, then dropped by 1.8% to $10.9 million in 2016, then surged by 76.15% to $19.2 million in 2017, then changed by 0.0% to $19.2 million in 2018, then plunged by 56.25% to $8.4 million in 2019.
• Business Quant data shows UTHR's Preferred Stock Liabilities at $8.4 million in Q2 2019, $19.2 million in Q1 2019, and $19.2 million in Q4 2018.